Four genes were identified and validated in all databases, showing a significantly altered expression in melanoma vs. controls, namely NOD2, BAX, IL-18 and ADRB2, NOD2 and IL-18 appear to be particularly interesting from a prognostic point of view since their expression was also found to be related to a significant survival improvement (Figure 7). The gene discussed is NOD2; the disease is melanoma.